5HT1F receptor agonists and mitochondrial biogenesis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11014892
SERIAL NO

16347163

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MUSC FOUNDATION FOR RESEARCH DEVELOPMENT135 CANNON STREET SUITE 101L CHARLESTON SC 29425

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beeson, Craig C Charleston, US 15 8
Lindsey, Christopher C Wadmalaw Island, US 11 5
Peterson, Yuri Karl Charleston, US 3 1
Schnellmann, Rick G Tucson, US 7 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 25, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 25, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 25, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00